Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIO-RAD LABORATORIES, INC.BIO BIO.B · Entity 2247 | EVP, General Counsel & Sec | September 04, 2026 | September 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIO-RAD LABORATORIES, INC.
Report date September 04, 2026 · Filed September 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Bio-Rad A Common StockSEC Table I · non-derivative | Direct | 1,651.777 |
Ending reported balance
After 2026-09-06 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-09-05 · Exercise / conversion · Acquired 685 · Balance 1,434.777 F1: Shares of Class A common stock acquired on the vesting of restricted stock units. Row 2 · 2026-09-05 · Tax withholding · Disposed 246 · Balance 1,188.777 Row 3 · 2026-09-06 · Exercise / conversion · Acquired 768 · Balance 1,956.777 F1: Shares of Class A common stock acquired on the vesting of restricted stock units. Row 4 · 2026-09-06 · Tax withholding · Disposed 305 · Balance 1,651.777 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 2,876 |
Reported balance
After 2026-09-04 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-04 · Grant · Acquired 2,876 · Balance 2,876 F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 2,055 |
Reported balance
After 2026-09-05 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-05 · Exercise / conversion · Disposed 685 · Balance 2,055 F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 1,536 |
Reported balance
After 2026-09-06 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-06 · Exercise / conversion · Disposed 768 · Balance 1,536 F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter.
F4: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 06, 2026 Filed Sep 9, 2026 22:45 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 768 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002019843-26-000004 · wk-form4_1788993899.xml · derivative · entry 7 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,536 Underlying: Bio-Rad A Common Stock · 768 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:45 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 305 | $386.11 | $117,763.55 |
DisclosureSEC source: 0002019843-26-000004 · wk-form4_1788993899.xml · nonDerivative · entry 4 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,651.777 Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:45 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 768 | $0.00 | $0.00 |
DisclosureSEC source: 0002019843-26-000004 · wk-form4_1788993899.xml · nonDerivative · entry 3 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,956.777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:45 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 685 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002019843-26-000004 · wk-form4_1788993899.xml · derivative · entry 6 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,055 Underlying: Bio-Rad A Common Stock · 685 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:45 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 246 | $386.11 | $94,983.06 |
DisclosureSEC source: 0002019843-26-000004 · wk-form4_1788993899.xml · nonDerivative · entry 2 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,188.777 Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:45 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 685 | $0.00 | $0.00 |
DisclosureSEC source: 0002019843-26-000004 · wk-form4_1788993899.xml · nonDerivative · entry 1 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,434.777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 22:45 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | GrantRestricted Stock Units · Derivative | 2,876 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002019843-26-000004 · wk-form4_1788993899.xml · derivative · entry 5 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,876 Underlying: Bio-Rad A Common Stock · 2,876 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. F3 · derivative.expiration_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 16:20 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 186 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002019843-26-000002 · wk-form4_1777393201.xml · derivative · entry 3 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 372 Underlying: Bio-Rad A Common Stock · 186 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On April 24, 2024, the reporting person was granted 744 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On April 24, 2024, the reporting person was granted 744 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 16:20 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 77 | $287.84 | $22,163.68 |
DisclosureSEC source: 0002019843-26-000002 · wk-form4_1777393201.xml · nonDerivative · entry 2 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 749.777 Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 16:20 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 186 | $0.00 | $0.00 |
DisclosureSEC source: 0002019843-26-000002 · wk-form4_1777393201.xml · nonDerivative · entry 1 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 826.777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 6.1520 and 5.6340 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2025 and 12/31/2025, respectively. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:20 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 768 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002019843-25-000005 · wk-form4_1757449221.xml · derivative · entry 4 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,304 Underlying: Bio-Rad A Common Stock · 768 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:20 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 275 | $295.43 | $81,243.25 |
DisclosureSEC source: 0002019843-25-000005 · wk-form4_1757449221.xml · nonDerivative · entry 2 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 628.991 Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:20 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 768 | $0.00 | $0.00 |
DisclosureSEC source: 0002019843-25-000005 · wk-form4_1757449221.xml · nonDerivative · entry 1 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 903.991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 6.5980 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2025. Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:20 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | GrantRestricted Stock Units · Derivative | 2,740 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002019843-25-000005 · wk-form4_1757449221.xml · derivative · entry 3 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,740 Underlying: Bio-Rad A Common Stock · 2,740 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| April 24, 2025 Filed Apr 25, 2025 22:06 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 186 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-008077 · form4.xml · derivative · entry 3 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 558 Underlying: Bio-Rad A Common Stock · 186 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On April 24, 2024, the reporting person was granted 744 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On April 24, 2024, the reporting person was granted 744 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| April 24, 2025 Filed Apr 25, 2025 22:06 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 67 | $249.74 | $16,732.58 |
DisclosureSEC source: 0001062993-25-008077 · form4.xml · nonDerivative · entry 2 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129.393 Read SEC document |
| April 24, 2025 Filed Apr 25, 2025 22:06 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 186 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-008077 · form4.xml · nonDerivative · entry 1 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196.393 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 5.5730 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2025. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:55 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,946 | $0.00 Strike: $256.45 | $0.00 |
DisclosureSEC source: 0001062993-25-004596 · form4.xml · derivative · entry 2 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,946 Underlying: Bio-Rad A Common Stock · 1,946 shares Expires 2035-03-03 F2 · derivative.exercise_date: The stock option vests over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 18:28 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | GrantRestricted Stock Units · Derivative | 3,072 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016396 · form4.xml · derivative · entry 1 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,072 Underlying: Bio-Rad A Common Stock · 3,072 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F2 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| April 24, 2024 Filed Apr 29, 2024 22:12 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | GrantRestricted Stock Units · Derivative | 744 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-009013 · form4.xml · derivative · entry 1 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 744 Underlying: Bio-Rad A Common Stock · 744 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F2 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.